Skip to main content
SpringerLink
Log in

Appearance of anti TSH-receptor antibodies and clinical Graves’ disease after radioiodine therapy for hyperfunctioning thyroid adenoma

  • Case Report
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Radioiodine treatment use is frequent in patients with benign hyperfunctioning thyroid diseases and the side-effects are rare. In this paper we described the appearance of TSH-receptor antibodies and the concomitant development of persistent hyperthyroidism in a patient with hyperfunctioning thyroid adenoma after 131I treatment. A 70-year-old man presented a hyperfunctioning thyroid adenoma with suppressed uptake in the adjacent normal gland. Antibodies against the thyroglobulin (TgAb), thyroid peroxidase (TPOAb) and TSH-receptor (TRAb) were absent. One year after remission by radioiodine therapy the patient developed severe and persistent hyperthyroidism associated with diffuse 131I uptake in the gland. TgAb and TPOAb remained absent, but TRAb were present. Although spontaneous development of Graves’ disease cannot be excluded, the time sequence and the negative familial and personal history for autoimmune diseases suggest a possible connection between the two phenomena. The release of TSH-receptor antigen from follicular cells damaged by 131I may have triggered the autoimmune response turning a toxic nodular goiter patient into a Graves’ disease patient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. McGregor A.M., Petersen M.M., Capiferri R., Evered D.C., Smith B.R., Hall R. Effects of radioiodine on thyrotropin binding inhibiting immunoglobulins in Graves’ disease. Clin. Endocrinol. 11: 437, 1979.

    Article  CAS  Google Scholar 

  2. Weetman A.P., McGregor A.M. Autoimmune thyroid disease: development in our understanding. Endocr. Rev. 5: 309, 1984.

    Article  CAS  PubMed  Google Scholar 

  3. McGregor A.M., McLachlan S.M., Smith B.R., Hall R. Effect of irradiation on thyroid-autoantibody production. Lancet 2: 442, 1979.

    CAS  PubMed  Google Scholar 

  4. Feldt-Rasmussen U., Bech K., Date J., Petersen P.H., Johansen K., Madsen S.N. Thyroid stimulating antibodies, thyroglobulin antibodies and serum proteins during antithyroid treatment with radioiodine or propyltiouracil of Graves’ disease. Allergy 32: 161, 1982.

    Article  Google Scholar 

  5. Walfish P.G., Caplan D., Rosen I.D. Post-parathyroidectomy transient thyrotoxicosis. J. Clin. Endocrinol. Metab. 75: 224, 1992.

    CAS  PubMed  Google Scholar 

  6. Werner S.C. Graves’ disease following acute (subacute) thyroiditis. Arch. Intern. Med. 139: 1313, 1979.

    Article  CAS  PubMed  Google Scholar 

  7. Monzani F., Caraccio N., Goletti O., Lippolis P.V., Casolaro A., Del Guerra P., Cavina E., Miccoli P. Five-year follow-up of percutaneous ethanol injection for the treatment of hyperfunctioning thyroid nodule: a study of 117 patients. Clin. Endocrinol. (Oxf.) 46: 9, 1997.

    Article  CAS  Google Scholar 

  8. Monzani F., Del Guerra P, Caraccio N., Casolaro A., Lippolis P. V., Goletti O. Appearance of Graves’ disease after percutaneous ethanol injection for the treatment of hyperfunctioning thyroid adenoma. J. Endocrinol. Invest. 20: 294, 1997.

    Article  CAS  PubMed  Google Scholar 

  9. Smyth P.P.A., Neylan D., MacMullan N.M., Smith D.F., McKenna T.J. Sequential presentation of a case of hyperthyroidism with autonomously functioning nodules and Graves’ disease in the presence of IgG thyroid stimulators. Acta Endocrinol. (Copenh.) 118: 474, 1988.

    CAS  Google Scholar 

  10. Boddemberg B., Voth E., Schicha H. Immunogene Hyperthyreose nach radiojod-Ablation einer fokalen Autonomie. Nuclearmedizin 32: 18, 1993.

    Google Scholar 

  11. Chiovato L., Santini F., Vitti P., Bendinelli G., Pinchera A. Appearance of thyroid stimulating antibody and Graves’ disease after radioiodine therapy for toxic nodule. Clin. Endocrinol. (Oxf.) 40: 803, 1994.

    Article  CAS  Google Scholar 

  12. David E., Rosen I.B., Bain J., James J., Kirsh J.C. Management of the hot thyroid nodule. Am. J. Surg. 170: 481, 1995.

    Article  CAS  PubMed  Google Scholar 

  13. Nygaard B., Faber J., Veje A., Hegedus L., Hansen J.M. Appearance of Graves’-like disease after radioiodine for toxic as well as non-toxic multinodular goitre. Clin. Endocrinol. (Oxf.) 43: 129, 1995.

    Article  CAS  Google Scholar 

  14. Kay T.W.H., Heyma P., Harrison L.C., Martin F.I.R. Graves’ disease induced by radioactive iodine. Ann. Intern. Med. 107: 857, 1987.

    Article  CAS  PubMed  Google Scholar 

  15. Nygaard B., Knudsen J.K., Hegedus L., Scient A.V.C., Hansen J.E.M. Thyrotropin receptor antibodies and Graves’ disease, a side-effect of 131I treatment in patients with non nontoxic goiter. J. Clin. Endocrinol. Metab. 82: 2928, 1997.

    Google Scholar 

  16. Huysmans D.A.K.C., Hermus A.R.M.M., Edelbroek M.A.L., Tjabbes T., Oostdijk A., Ross H.A., Corstens F.H.M., Kloppenborg P.W.C. Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goiter. Thyroid 7: 535, 1997.

    Article  CAS  PubMed  Google Scholar 

  17. Brun J., Block U., Ruf G., Bos I., Kunze W.P., Scriba P.C. Volumetrie der Schilddrusenlappen mittels Real-Time Sonographie. Dtsch. Med. Wochenschr. 106: 1338, 1981.

    Article  Google Scholar 

  18. Studer H., Gerber H., Peter H.J. Multinodular goiter. In: DeGroot L.J., (Ed.), Endocrinology. W.B. Saunders, Philadelphia, 1989, p. 722.

  19. Beck K. Immunological aspects of Graves’ disease and importance of thyroid stimulating immunoglobulins. Acta Endocrinol. (Copenh.) 254 (Suppl.): 1, 1983.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Istituto di Medicina, Interna, Malattie Endocrine e del Metabolismo, Università di Catania, Ospedale Garibaldi, Piazza S. Maria di Gesù, 95123, Catania, Italy

    Concetto Regalbuto M.D., S. Salamone, C. Scollo, R. Vigneri & V. Pezzino

Authors
  1. Concetto Regalbuto M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Salamone
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Scollo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Vigneri
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. V. Pezzino
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Regalbuto, C., Salamone, S., Scollo, C. et al. Appearance of anti TSH-receptor antibodies and clinical Graves’ disease after radioiodine therapy for hyperfunctioning thyroid adenoma. J Endocrinol Invest 22, 147–150 (1999). https://doi.org/10.1007/BF03350896

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03350896

Key-words

Search

Navigation